Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphoma

Medical Oncology

Volumn 27, Issue 3, 2010, Pages 798-806

  Ma, Hui Hui ^a   Qian, Li Ting ^a   Pan, Hai Feng ^a   Yang, Lin ^a   Zhang, Hong Yan ^a   Wang, Zhi Hua ^a   Ma, Jun ^a   Zhao, Yu Fei ^a   Gao, Jin ^a   Wu, Ai Dong ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Nasal lymphoma; NK T cell lymphoma; Prognostic factors; Treatment

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; MITOXANTRONE; PREDNISOLONE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NK T CELL LYMPHOMA; NOSE CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOMA, EXTRANODAL NK-T-CELL; MALE; MIDDLE AGED; MITOXANTRONE; NOSE NEOPLASMS; PARANASAL SINUS NEOPLASMS; PREDNISOLONE; PREDNISONE; RADIOISOTOPE TELETHERAPY; RADIOTHERAPY, HIGH-ENERGY; TREATMENT OUTCOME; VINCRISTINE; YOUNG ADULT;

EID: 77956914232     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9288-7     Document Type: Article

References (40)

1. I Cuadra-Garcia, et al. 1999 Sinonasal lymphoma: a clinicopathologic analysis of 58 cases from the Massachusetts General Hospital Am J Surg Pathol 23 1356 1369 10.1097/00000478-199911000-00006 10555004 1:STN:280: DC%2BD3c%2FitFCktw%3D%3D (Pubitemid 29517329)
2. KJ Savage M Chhanabhai RD Gascoyne JM Connors 2004 Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification Ann Oncol 15 1467 1475 10.1093/annonc/mdh392 15367405 1:STN:280:DC%2BD2cvlvVGqtw%3D%3D (Pubitemid 39409735)
3. C Grau, et al. 2001 Sino-nasal cancer in Denmark 1982-1991: a nationwide survey Acta Oncol 40 19 23 10.1080/028418601750070993 11321654 1:STN:280:DC%2BD3M3jvVaksQ%3D%3D (Pubitemid 32234587)
4. A Aviles L Rodriguez R Guzman A Talavera EL Garcia JC Diaz-Maqueo 1992 Angiocentric T-cell lymphoma of the nose, paranasal sinuses and hard palate Hematol Oncol 10 141 147 10.1002/hon.2900100303 1398510 1:STN:280: DyaK3s%2FhtlGmug%3D%3D
5. MM Cheung, et al. 1998 Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients J Clin Oncol 16 70 77 9440725 1:STN:280:DyaK1c7gtFKktw%3D%3D
6. ES Jaffe, et al. 1996 Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas: definitions, differential diagnosis and epidemiology Am J Surg Pathol 20 103 111 10.1097/00000478-199601000-00012 8540601 1:STN:280:DyaK287jtVahug%3D%3D
7. GE Kim, et al. 2000 Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment J Clin Oncol 18 54 63 10623693 1:STN:280:DC%2BD3c%2FptV2ksA%3D%3D
8. YH Ko, et al. 1998 REAL classification of malignant lymphomas in the Republic of Korea Cancer 83 806 812 10.1002/(SICI)1097-0142(19980815)83: 4<806::AID-CNCR26>3.3.CO;2-8 9708949 1:STN:280:DyaK1cznt1Krsg%3D%3D
9. R Liang, et al. 1995 Treatment outcome and prognostic factors for primary nasal lymphoma J Clin Oncol 13 666 670 7884427 1:STN:280:DyaK2M7ptVGitA%3D%3D
10. L Quintanilla-Martinez, et al. 1999 Histological and immunophenotypic profile of nasal NK/T-cell lymphomas from Peru: high prevalence of p53 overexpression Hum Pathol 30 849 855 10.1016/S0046-8177(99)90147-8 10414505 1:STN:280:DyaK1MzktFCmtw%3D%3D (Pubitemid 29325793)
11. K Gaal NC Sun AM Hernandez DA Arber 2000 Sinonasal NK/T-cell lymphomas in the United States Am J Surg Pathol 24 1511 1517 10.1097/00000478-200011000- 00006 11075852 1:STN:280:DC%2BD3M%2FjtlGktw%3D%3D
12. NL Harris, et al. 1994 A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group Blood 84 1361 1392 8068936 1:STN:280:DyaK2czkvVSmtQ%3D%3D
13. MM Cheung JK Chan WH Lau RK Ngan WW Foo 2002 Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality Int J Radiat Oncol Biol Phys 54 182 190 12182990
14. Y Harabuchi, et al. 1996 Nasal T-cell lymphoma causally associated with Epstein Barr virus: clinicopathologic, phenotypic, and genotypic studies Cancer 77 2137 2149 10.1002/(SICI)1097-0142(19960515)77:10<2137::AID-CNCR27>3.0. CO;2-V 8640683 1:STN:280:DyaK283gs1Sgtw%3D%3D (Pubitemid 26142062)
15. TT Kuo LY Shih NM Tsang 2004 Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities Int J Surg Pathol 12 375 387 10.1177/106689690401200410 15494863 1:CAS:528: DC%2BD2cXhtVCkt7vN (Pubitemid 39463506)
16. L Quintanilla-Martinez, et al. 2001 p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease Am J Pathol 159 2095 2105 11733360 1:CAS:528: DC%2BD38Xhslaqsg%3D%3D
17. T Hongyo, et al. 2005 p53, K-ras, c-kit and beta-catenin gene mutations in sinonasal NK/T-cell lymphoma in Korea and Japan Oncol Rep 13 265 271 15643509 1:CAS:528:DC%2BD2MXhsVGrtbk%3D
18. NL Harris, et al. 1999 World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting-Airlie House, Virginia, November 1997 J Clin Oncol 17 3835 3849 10577857 1:STN:280:DC%2BD3c%2FksVyltQ%3D%3D
19. GE Kim, et al. 2001 Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck Radiother Oncol 61 261 269 10.1016/S0167-8140(01)00428-5 11730995 1:STN:280:DC%2BD3MnosFKguw%3D%3D (Pubitemid 33127230)
20. WS Kim, et al. 2001 CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma? Ann Oncol 12 349 352 10.1023/A:1011144911781 11332147 1:STN:280:DC%2BD3MrhsFCjtQ%3D%3D (Pubitemid 32288691)
21. V Ribrag, et al. 2001 Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx Leukemia 15 1123 1126 10.1038/sj.leu. 2402148 11455983 1:STN:280:DC%2BD3MvgsFCjsw%3D%3D (Pubitemid 32717284)
22. A Avilés NR Díaz N Neri S Cleto A Talavera 2000 Angiocentric nasal T/natural killer cell lymphoma: a single centre study of prognostic factors in 108 patients Clin Lab Haematol 22 215 220 10.1046/j.1365-2257.2000.00307.x 11012633
23. Cheson BD, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol. 1999;17:1244.
24. EL Kaplan P Meier 1958 Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457 481 10.2307/2281868
25. N Mantel 1966 Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother Rep 50 163 170 5910392 1:STN:280:DyaF287ht1Wgug%3D%3D
26. DR Cox 1972 Regression models and life-tables (with discussion) J R Stat Soc B 34 187 220
27. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993;329:987-94.
28. HH Chen, et al. 1996 Experience of radiotherapy in lethal midline granuloma with special emphasis on centrofacial T-cell lymphoma: a retrospective analysis covering a 34-year period Radiother Oncol 38 1 6 10.1016/0167-8140(95) 01668-6 8850419 1:STN:280:DyaK2s%2FgtlSrsg%3D%3D (Pubitemid 26040262)
29. K Sakata, et al. 1997 Treatment of lethal midline granuloma type nasal T-cell lymphoma Acta Oncol 36 307 311 10.3109/02841869709001268 9208902 1:STN:280:DyaK2szlt1GjtQ%3D%3D
30. J Itami, et al. 1991 Non-Hodgkin's lymphoma confined to the nasal cavity: its relationship to the polymorphic reticulosis and results of radiation therapy Int J Radiat Oncol Biol Phys 20 797 802 2004957 1:STN:280: DyaK3M7mvFyksg%3D%3D
31. SR Smalley, et al. 1988 Polymorphic reticulosis limited to the upper aerodigestive tract-natural history and radiotherapeutic considerations Int J Radiat Oncol Biol Phys 15 599 605 3417488 1:STN:280:DyaL1czjtVGjtw%3D%3D
32. J Lee, et al. 2005 Nasal-type NK/T cell lymphoma: clinical features and treatment outcome Br J Cancer 92 1226 1230 10.1038/sj.bjc.6602502 15798768 1:STN:280:DC%2BD2M7nvVGrsg%3D%3D (Pubitemid 40604396)
33. YX Li, et al. 2006 Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma J Clin Oncol 24 181 189 10.1200/JCO.2005.03.2573 16382127 (Pubitemid 46630511)
34. YX Li, et al. 1998 Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy Cancer 83 449 456 10.1002/(SICI)1097-0142(19980801)83:3<449:: AID-CNCR13>3.0.CO;2-W 9690537 1:STN:280:DyaK1czlt1yntQ%3D%3D (Pubitemid 28354500)
35. KW Lee, et al. 2006 First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy ± radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma Leuk Lymphoma 47 1274 1282 10.1080/ 10428190600562823 16923557 1:CAS:528:DC%2BD28XhtFWksbrE
36. TM Kim, et al. 2005 Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage IE/IIE extranodal NK/T-cell lymphoma, nasal type Blood 106 3785 3790 10.1182/blood-2005-05-2056 16109779 1:CAS:528:DC%2BD2MXht12ksbbN (Pubitemid 41739013)
37. SJ Shim, et al. 2007 Clinical significance of cyclooxygenase-2 expression in extranodal natural killer (NK)/T-cell lymphoma, nasal type Int J Radiat Oncol Biol Phys 67 31 38 17049184 1:CAS:528:DC%2BD2sXpsleg
38. PP Carbone HS Kaplan K Musshoff DW Smithers M Tubiana 1971 Report of the committee on Hodgkin's disease staging classification Cancer Res 31 1860 1861 5121694 1:STN:280:DyaE38%2Fks1yitw%3D%3D
39. CS Chim, et al. 2004 Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index Blood 103 216 221 10.1182/blood-2003-05-1401 12933580 1:CAS:528: DC%2BD2cXhsFGitg%3D%3D (Pubitemid 38029941)
40. J Armitage J Vose D Weisenburger 2008 International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes J Clin Oncol 26 4124 4130 10.1200/JCO.2008.16.4558 18626005